Enoxaparin Dosing in Critically Ill Patients with Renal Impairment

Introduction to Enoxaparin Dosing

The American College of Cardiology recommends reducing enoxaparin to 30 mg subcutaneously once daily for prophylaxis in critically ill patients with severe renal impairment (CrCl <30 mL/min), as failure to adjust dosing results in a 2-3 fold increased bleeding risk 1, 2

For critically ill patients with severe renal impairment (CrCl <30 mL/min), the recommended prophylactic dose is 30 mg subcutaneously once daily, which represents a 25% dose reduction from the standard 40 mg daily prophylactic dose 1, 2
Enoxaparin clearance decreases by 44% in severe renal impairment, leading to drug accumulation that increases major bleeding risk nearly 4-fold (8.3% vs 2.4%) without dose adjustment 2

For therapeutic anticoagulation in critically ill patients with severe renal impairment (CrCl <30 mL/min), reduce enoxaparin to 1 mg/kg subcutaneously once daily, representing a 50% total daily dose reduction from the standard 1 mg/kg every 12 hours regimen 1, 2

Mandatory monitoring of anti-Xa levels is required in severe renal impairment (CrCl <30 mL/min) receiving prolonged treatment, with a target therapeutic range of 0.5-1.5 IU/mL for once-daily treatment dosing 1, 2

The American College of Cardiology recommends subcutaneous heparin 5000 units twice to three times daily for prophylaxis in patients with CrCl <30 mL/min as an alternative to enoxaparin 3
Unfractionated heparin is preferred for therapeutic anticoagulation in severe renal impairment when intensive monitoring is feasible, with a dosing regimen of 60 U/kg IV bolus followed by 12 U/kg/hour infusion 2

Elderly patients (≥70 years) with renal insufficiency require extreme caution due to LMWH accumulation risk, and tinzaparin should be avoided entirely in this population due to substantially higher mortality rates 1, 2, 5
Underweight patients (<50 kg) with renal impairment require close anti-Xa monitoring and reduced dosing 2
Avoid enoxaparin within 10-12 hours of neuraxial anesthesia to prevent spinal hematoma, regardless of renal function 1
Renal impairment takes absolute priority over weight-based dosing adjustments for prophylaxis, and do not increase prophylactic doses above 30 mg daily in patients with CrCl <30 mL/min, regardless of body weight 1